Adjective Health Launches Point-of-Care AI Platform to Bridge the Gap Between Clinical Conversations and Treatment Plan Follow-Through
Clinically designed platform supports greater patient understanding while delivering real-world intelligence that
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
![]()
Adjective Health today announced its entry into the healthcare technology market with a patient-first, clinically designed AI platform created to help people understand, remember and act on what they hear during clinical visits, while creating a new, consent-based channel for life sciences companies to identify unmet needs, deliver more relevant information and strengthen patient support. Adjective Health is bridging one of healthcare’s most consequential gaps by turning point-of-care conversations into a powerful new source of patient understanding, continuity of care and real-world intelligence.
Adjective Health was founded by Dr. John Reeves, a physician and healthcare technology entrepreneur who has spent more than three decades developing digital innovations for the life sciences industry.
“When I practiced medicine, I learned that 12 minutes in the exam room could shape the next 12 months of a patient’s care. Yet much of our conversation was forgotten before patients reached the parking lot,” said Dr. John Reeves, Founder and Board Chair of Adjective Health. “Patients can’t act on what they don’t remember or understand. Scribe technology gives us an opportunity to close that gap at scale, turning clinical conversations into lasting understanding, confidence and support. Adherence starts at the point of care, and so does adj/ctive.”
From Clinical Conversations to Patient Understanding
Unlike AI tools designed primarily to document a visit for clinicians or record a conversation, adj/ctive is built for patients, not the chart. With patient and healthcare provider consent, its technology captures point-of-care conversations and turns what was discussed into clear, plain-language visit summaries and relevant supporting resources. Patients can revisit what was discussed, better understand their next steps and access resources tailored to their condition, medication and stage of care. The patient-facing app, Adj/, is designed to put individuals in control of capturing their conversation, including the ability to stop or delete. The technology does not diagnose conditions, recommend treatment or replace clinical judgment, and decisions remain between patients and their healthcare providers.
“The opportunity is to make clinical conversations more useful for patients and the organizations supporting them,” said Marcos Mendell, Co-Founder and Chief Executive Officer of Adjective Health. “We’re creating a new point-of-care capability and channel that helps patients understand their care plan while giving life sciences companies insights into the questions, concerns and barriers shaping treatment decisions and follow through. These insights can make patient support more relevant, timely and effective.”
Adjective Health’s clinically designed AI platform turns consented point-of-care conversations into plain-language summaries and trusted education for patients. Healthcare partners can deliver their own approved, white-labeled content inside the experience, and with patient consent, they receive aggregated, de-identified insights into what patients hear, ask and need.
A New Opportunity for the Healthcare Industry
Life sciences companies and healthcare partners have long relied on claims, prescribing data, market research and digital engagement to understand patient journeys. While those sources provide valuable visibility, they offer limited insight into what patients need, what they struggle to understand, and the questions and concerns they raise during clinical visits. Adjective Health is designed to address these gaps and support treatment adherence.
Adjective Health is building a new intelligence layer around those unmet informational needs. With patient consent, aggregated, de-identified insights from conversations can help healthcare partners identify recurring questions, knowledge gaps and support needs.
By connecting the clinical encounter to ongoing patient engagement and actionable insights, adj/ctive is pursuing a scalable model for pharmaceutical manufacturers, biotechnology companies, hospital systems and patient organizations. The opportunity is not simply to distribute more content, but to make support more responsive to what patients need, while giving partners a clearer basis for refining programs and measuring their relevance.
As Adjective Health enters the market, the company is focused on establishing point-of-care conversation intelligence as a new approach to patient engagement, one that connects what happens during clinical visits with the understanding, insights and support needed afterward. By putting patients at the center, Adjective Health aims to help healthcare organizations better recognize and address barriers to treatment initiation, adherence and long-term care.
About Adjective Health
Adjective Health is a point-of-care adherence platform that helps people recall, understand, and act on what they hear during clinical visits. Founded by physicians and life sciences leaders, the company uses clinically designed AI to transform consented point-of-care conversations into plain-language summaries with relevant information, empowering patients to take greater control of their prescribed treatment plans. With patient consent, life sciences and healthcare partners receive aggregated, de-identified insights into real patient needs, enabling them to better deliver more relevant education and strengthen patient support programs. Headquartered in Toronto, Canada. Visit www.AdjectiveHealth.ai to learn more.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261119970483/en/
Media gallery

